Recently, the epidemic situation in China has continued to escalate, and the global epidemic situation has shown an improvement trend. Recently, a new round of epidemic in China has struck again. As of March 12, the average daily number of confirmed cases in 31 provinces (autonomous regions and municipalities directly under the central government) and Xinjiang production and Construction Corps in March was 495, and the average daily number of confirmed cases in Hong Kong was 14569; Among them, on March 12, there were 1938 new confirmed cases (1807 local cases) in 31 provinces (autonomous regions and municipalities directly under the central government) and Xinjiang production and Construction Corps, and 3719 new confirmed cases in Hong Kong. Since the epidemic peak in January, the global epidemic began to improve, and the number of newly confirmed cases per day showed a downward trend. In February, there were 2.08 million newly confirmed cases per day, down 28% from January; As of March 12, there were 1.6 million new confirmed cases in March, down 23% from February.
Update of global epidemic prevention and entry-exit policy: India will resume international passenger flights from March 27; Malaysia will open its border on April 1 and lift many epidemic prevention restrictions in China; South Korea will exempt immigrants who have completed covid-19 vaccination from quarantine from March 21; IAA and the European Council of international airports call on EU countries to lift covid-19 related tourism restrictions. At present, 10 EU and Schengen countries are implementing it; The Philippines plans to open its entry to passengers from all countries in April; The United States adjusted the risk level of Thailand, New Zealand and Hong Kong to the highest level 4.
From January to February, the main business data came out: the profit margin of China tax exemption exceeded expectations, and the sales of domestic cosmetics increased steadily. From January to February, China free achieved a revenue of about 13.1 billion yuan, a year-on-year increase of about 20%; The net profit attributable to the parent company was about 2.4 billion yuan, with a year-on-year increase of about 20%, and the net interest rate attributable to the parent company was about 18.3%, which was basically flat compared with the same period last year, and the Q3 / Q4 (non deduction) increased by about 9.3pct and 12.2pct compared with last year. From January to February, Proya Cosmetics Co.Ltd(603605) achieved a total operating income of about 630 million yuan, an increase of about 30% year-on-year, and a net profit attributable to the parent company of about 60 million yuan, an increase of about 35% year-on-year Bloomage Biotechnology Corporation Limited(688363) achieved a total operating income of about 640 million yuan, an increase of about 55% year-on-year Lushang Health Industry Development Co.Ltd(600223) cosmetics achieved a revenue of 22000 yuan, a year-on-year increase of 146.7%.
Key investment and financing events this week: Sichuan spicy hot brand “spicy dish” completed a round of financing of ten million yuan, Xinjiang cultural catering chain brand “Xinjiang Xiaoluo” completed a round of seed financing, Hamburg fast food brand “guster Hamburg” completed a round of financing, and catering supply chain service provider “xinliangji” won C round of investment; The second-hand clothing e-commerce platform “upty” received 650000 euros of seed round financing, and the second-hand watch idle trading platform “Zhongbiao” completed millions of yuan of angel round financing; The special research technology skin care brand “youngmay sample beauty” won tens of millions of pre-A round of financing; The camping and vacation platform “Hi King wild luxury camp” received one million yuan Angel round financing.
Investment recommendations: recommendations: recommendations focus on the Btg Hotels (Group) Co.Ltd(600258) China Tourism Group Duty Free Corporation Limited(601888) , Yunnan Botanee Bio-Technology Group Co.Ltd(300957) , Proya Cosmetics Co.Ltd(603605) Shanghai Jahwa United Co.Ltd(600315) , Chow Tai Seng Jewellery Company Limited(002867) , Henan Liliang Diamond Co.Ltd(301071) , Imeik Technology Development Co.Ltd(300896) , Bloomage Biotechnology Corporation Limited(688363) , Yonghe medical in the gold and jewelry sector, medical and beauty sector.
Risk tip: macroeconomic fluctuation risk, repeated epidemic situation and intensified industry competition.
